• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Bruton Tyrosine Kinase Inhibitors in Leukemia and Lymphoma

home / peer-exchange / bruton-tyrosine-kinase-inhibitors-in-leukemia-and-lymphoma

A panel of experts provide an overview of the disease burden associated with leukemia and lymphoma, discuss the current treatment landscape of BTK inhibitors, and offer payer considerations in treatment management.

© 2024 MJH Life Sciences
All rights reserved.